Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Verlicchi

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Translational Lung Cancer Research|March 10, 2016
Cancer stem cells in small cell lung cancerJordi Codony-Servat, Alberto Verlicchi, Rafael Rosell
Future Oncology (London, England)|August 4, 2015
Benefit of eribulin in a patient with HER2(+) breast cancer who progressed after trastuzumab and lapatinib: a case reportClaudia Casanova, Alberto Verlicchi, Valentina Mazza, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 22, 2016
HER3 as a Therapeutic Target in CancerNiki Karachaliou, Chiara Lazzari, Alberto Verlicchi, et al.
Lung Cancer (Auckland, N.Z.)|April 10, 2019
Targeting RET-rearranged non-small-cell lung cancer: future prospectsGiuseppe Bronte, Paola Ulivi, Alberto Verlicchi, et al.
Biology|February 26, 2026
Overcoming Immunotherapy Resistance in Small-Cell Lung CancerMatteo Canale, Fabrizia Suzzi, Alberto Verlicchi, et al.
Journal of Oncology|September 19, 2019
Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung CancerSerena De Matteis, Matteo Canale, Alberto Verlicchi, et al.
Translational Lung Cancer Research|December 21, 2019
New generation anaplastic lymphoma kinase inhibitorsAngelo Delmonte, Marco Angelo Burgio, Alberto Verlicchi, et al.
Expert Review of Respiratory Medicine|May 4, 2017
Second-line therapy of squamous non-small cell lung cancer: an evolving landscapeChiara Lazzari, Niki Karachaliou, Vanesa Gregorc, et al.
International Journal of Molecular Sciences|November 25, 2023
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung CancerKalliopi Andrikou, Tania Rossi, Alberto Verlicchi, et al.
Life (Basel, Switzerland)|September 28, 2023
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung CancerAlberto Verlicchi, Matteo Canale, Elisa Chiadini, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Translational Lung Cancer Research|March 10, 2016
Cancer stem cells in small cell lung cancerJordi Codony-Servat, Alberto Verlicchi, Rafael Rosell
Future Oncology (London, England)|August 4, 2015
Benefit of eribulin in a patient with HER2(+) breast cancer who progressed after trastuzumab and lapatinib: a case reportClaudia Casanova, Alberto Verlicchi, Valentina Mazza, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 22, 2016
HER3 as a Therapeutic Target in CancerNiki Karachaliou, Chiara Lazzari, Alberto Verlicchi, et al.
Lung Cancer (Auckland, N.Z.)|April 10, 2019
Targeting RET-rearranged non-small-cell lung cancer: future prospectsGiuseppe Bronte, Paola Ulivi, Alberto Verlicchi, et al.
Biology|February 26, 2026
Overcoming Immunotherapy Resistance in Small-Cell Lung CancerMatteo Canale, Fabrizia Suzzi, Alberto Verlicchi, et al.
Journal of Oncology|September 19, 2019
Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung CancerSerena De Matteis, Matteo Canale, Alberto Verlicchi, et al.
Translational Lung Cancer Research|December 21, 2019
New generation anaplastic lymphoma kinase inhibitorsAngelo Delmonte, Marco Angelo Burgio, Alberto Verlicchi, et al.
Expert Review of Respiratory Medicine|May 4, 2017
Second-line therapy of squamous non-small cell lung cancer: an evolving landscapeChiara Lazzari, Niki Karachaliou, Vanesa Gregorc, et al.
International Journal of Molecular Sciences|November 25, 2023
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung CancerKalliopi Andrikou, Tania Rossi, Alberto Verlicchi, et al.
Life (Basel, Switzerland)|September 28, 2023
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung CancerAlberto Verlicchi, Matteo Canale, Elisa Chiadini, et al.
Pageof 3